Market Research Logo

Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review

Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodysplastic syndromes, beta-thalassemia and myelofibrosis. It also offers pipeline products for the treatment of facioscapulohumeral muscular dystrophy, neuromuscular diseases, renal cell carcinoma and other indications. The company partners with various biopharmaceutical companies and research institutes to advance the development of its lead products. AcceleronPharma is headquartered in Cambridge, Massachusetts, the US.

Acceleron Pharma Inc Key Recent Developments

Nov 15,2017: Acceleron Announces Appointment of Dr. Karen Smith to its Board of Directors and Departure of Terrance McGuire
Sep 12,2017: Acceleron to Host Research and Development Day on September 19, 2017
Aug 03,2017: Acceleron Pharma Reports Second Quarter 2017 Operational and Financial Results
May 08,2017: Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results
May 02,2017: Acceleron Announces Management Change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Acceleron Pharma Inc - Key Facts 5
Acceleron Pharma Inc - Key Employees 6
Acceleron Pharma Inc - Key Employee Biographies 7
Acceleron Pharma Inc - Major Products and Services 8
Acceleron Pharma Inc - History 9
Acceleron Pharma Inc - Company Statement 10
Acceleron Pharma Inc - Locations And Subsidiaries 13
Head Office 13
Section 2 – Company Analysis 14
Company Overview 14
Acceleron Pharma Inc - Business Description 14
R&D Overview 14
Acceleron Pharma Inc - Corporate Strategy 15
Acceleron Pharma Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Acceleron Pharma Inc - Strengths 16
Acceleron Pharma Inc - Weaknesses 17
Acceleron Pharma Inc - Opportunities 18
Acceleron Pharma Inc - Threats 19
Acceleron Pharma Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Acceleron Pharma Inc, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Nov 15, 2017: Acceleron Announces Appointment of Dr. Karen Smith to its Board of Directors and Departure of Terrance McGuire 32
Sep 12, 2017: Acceleron to Host Research and Development Day on September 19, 2017 33
Aug 03, 2017: Acceleron Pharma Reports Second Quarter 2017 Operational and Financial Results 34
May 08, 2017: Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results 36
May 02, 2017: Acceleron Announces Management Change 38
Mar 01, 2017: Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results 39
Jan 06, 2017: Acceleron Outlines Corporate Goals and Priorities for 2017 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Acceleron Pharma Inc, Key Facts 5
Acceleron Pharma Inc, Key Employees 6
Acceleron Pharma Inc, Key Employee Biographies 7
Acceleron Pharma Inc, Major Products and Services 8
Acceleron Pharma Inc, History 9
Acceleron Pharma Inc, Key Competitors 20
Acceleron Pharma Inc, Ratios based on current share price 21
Acceleron Pharma Inc, Annual Ratios 22
Acceleron Pharma Inc, Annual Ratios (Cont...1) 23
Acceleron Pharma Inc, Annual Ratios (Cont...2) 24
Acceleron Pharma Inc, Interim Ratios 26
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Acceleron Pharma Inc, Recent Deals Summary 31
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45
List of Figures
Acceleron Pharma Inc, Performance Chart (2012 - 2016) 25
Acceleron Pharma Inc, Ratio Charts 27
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report